# Pfizer (PFE) SEC filings: latest 10-K, 10-Q and 8-K

URL: https://funkfolio.com/stock/PFE/filings

> Pfizer (PFE) SEC filings from EDGAR: 10-K filed Feb 26, 2026, 10-Q filed Nov 3, 2026, 8-K filed Nov 3, 2026. 124 filings in the last 12 months.

---

## Pfizer (PFE) SEC filings

Pfizer's latest annual report is a Form 10-K filed on February 26, 2026 for the period ended December 31, 2025. Its latest quarterly report, a Form 10-Q, was filed on November 3, 2026. Its latest current report, a Form 8-K, was filed on November 3, 2026. EDGAR lists 124 filings for it in the last twelve months.

### Key facts

- **Latest annual report:** 10-K, Feb 26, 2026
- **Latest quarterly report:** 10-Q, Nov 3, 2026
- **Latest 8-K:** 8-K, Nov 3, 2026
- **Filings, last 12 months:** 124
- **Insider forms, last 12 months:** 90 Forms 3, 4 and 5
- **13D and 13G, last 12 months:** 7
- **SEC central index key:** 0000078003

Filings as listed by SEC EDGAR at Nov 18, 2026, 04:19 UTC (re-read at most hourly). Source: [SEC EDGAR filings for CIK 0000078003](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000078003). Every form links to its document on sec.gov. Older filings are in EDGAR's archive; the tables here cover its recent list (at least the last year).

### Annual and quarterly reports

Pfizer: annual and quarterly reports filed with the SEC

| Form | Filed | Period ended | Document |
| --- | --- | --- | --- |
| [10-Q](https://www.sec.gov/Archives/edgar/data/78003/000007800326000127/pfe-20260927.htm) | Nov 3, 2026 | Sep 27, 2026 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/78003/000007800326000095/pfe-20260628.htm) | Aug 4, 2026 | Jun 28, 2026 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/78003/000007800326000054/pfe-20260329.htm) | May 5, 2026 | Mar 29, 2026 | Quarterly report |
| [10-K](https://www.sec.gov/Archives/edgar/data/78003/000007800326000026/pfe-20251231.htm) | Feb 26, 2026 | Dec 31, 2025 | Annual report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/78003/000007800325000150/pfe-20250928.htm) | Nov 4, 2025 | Sep 28, 2025 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/78003/000007800325000138/pfe-20250629.htm) | Aug 5, 2025 | Jun 29, 2025 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/78003/000007800325000114/pfe-20250330.htm) | May 5, 2025 | Mar 30, 2025 | Quarterly report |
| [10-K](https://www.sec.gov/Archives/edgar/data/78003/000007800325000054/pfe-20241231.htm) | Feb 27, 2025 | Dec 31, 2024 | Annual report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/78003/000007800324000191/pfe-20240929.htm) | Nov 4, 2024 | Sep 29, 2024 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/78003/000007800324000166/pfe-20240630.htm) | Aug 5, 2024 | Jun 30, 2024 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/78003/000007800324000107/pfe-20240331.htm) | May 8, 2024 | Mar 31, 2024 | Quarterly report |
| [10-K](https://www.sec.gov/Archives/edgar/data/78003/000007800324000039/pfe-20231231.htm) | Feb 22, 2024 | Dec 31, 2023 | Annual report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/78003/000007800323000115/pfe-20231001.htm) | Nov 8, 2023 | Oct 1, 2023 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/78003/000007800323000088/pfe-20230702.htm) | Aug 9, 2023 | Jul 2, 2023 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/78003/000162828023017196/pfe-20230402.htm) | May 10, 2023 | Apr 2, 2023 | Quarterly report |
| [10-K](https://www.sec.gov/Archives/edgar/data/78003/000007800323000024/pfe-20221231.htm) | Feb 23, 2023 | Dec 31, 2022 | Annual report |

The latest 16 of 23 in EDGAR's recent list. Amended reports are marked. The period is the fiscal year or quarter the report covers.

### Current reports (8-K)

Pfizer: current reports on Form 8-K and the items each reports

| Form | Filed | Event date | What it reports |
| --- | --- | --- | --- |
| [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800326000132/pfe-20261030.htm) | Nov 3, 2026 | Oct 30, 2026 | 5.02 Departure or Election of Directors or Officers; Officer Compensation 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800326000125/pfe-20261103.htm) | Nov 3, 2026 | Nov 3, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800326000094/pfe-20260804.htm) | Aug 4, 2026 | Aug 4, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800326000087/pfe-20260618.htm) | Jun 18, 2026 | Jun 18, 2026 | 7.01 Regulation FD Disclosure |
| [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800326000085/pfe-20260618.htm) | Jun 18, 2026 | Jun 18, 2026 | 5.02 Departure or Election of Directors or Officers; Officer Compensation 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800326000053/pfe-20260505.htm) | May 5, 2026 | May 5, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800326000044/pfe-20260423.htm) | Apr 27, 2026 | Apr 23, 2026 | 5.07 Submission of Matters to a Vote of Security Holders |
| [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800326000005/pfe-20260203.htm) | Feb 3, 2026 | Feb 3, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800325000167/pfe-20251216.htm) | Dec 16, 2025 | Dec 16, 2025 | 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/78003/000119312525291406/d80089d8k.htm) | Nov 21, 2025 | Nov 18, 2025 | 8.01 Other Events 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800325000159/pfe-20251113.htm) | Nov 13, 2025 | Nov 13, 2025 | 8.01 Other Events |
| [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800325000149/pfe-20251104.htm) | Nov 4, 2025 | Nov 4, 2025 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800325000136/pfe-20250805.htm) | Aug 5, 2025 | Aug 5, 2025 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/78003/000119312525122480/d60311d8k.htm) | May 19, 2025 | May 14, 2025 | 8.01 Other Events 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800325000111/pfe-20250429.htm) | Apr 29, 2025 | Apr 29, 2025 | 2.02 Results of Operations and Financial Condition 2.05 Costs Associated with Exit or Disposal Activities 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800325000109/pfe-20250424.htm) | Apr 28, 2025 | Apr 24, 2025 | 5.07 Submission of Matters to a Vote of Security Holders |
| [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800325000017/pfe-20250204.htm) | Feb 4, 2025 | Feb 4, 2025 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800324000195/pfe-20241217.htm) | Dec 17, 2024 | Dec 17, 2024 | 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800324000188/pfe-20241029.htm) | Oct 29, 2024 | Oct 29, 2024 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800324000185/pfe-20241010.htm) | Oct 15, 2024 | Oct 10, 2024 | 5.02 Departure or Election of Directors or Officers; Officer Compensation 9.01 Financial Statements and Exhibits |

The latest 20 of 62 in EDGAR's recent list. Item names are the SEC's own, from Form 8-K (a few long ones shortened). The event date is the date of the earliest event reported.

### Insider forms (3, 4 and 5)

Pfizer: insider forms 3, 4 and 5 filed per month over the last twelve months

| Month | Forms filed |
| --- | --- |
| Nov 2026 | 2 |
| Oct 2026 | 3 |
| Sep 2026 | 8 |
| Aug 2026 | 7 |
| Jul 2026 | 3 |
| Jun 2026 | 9 |
| May 2026 | 2 |
| Apr 2026 | 16 |
| Mar 2026 | 19 |
| Feb 2026 | 11 |
| Jan 2026 | 8 |
| Dec 2025 | 2 |

Pfizer: the latest insider forms

| Form | Filed | Transaction date |
| --- | --- | --- |
| [4](https://www.sec.gov/Archives/edgar/data/78003/000122520826009022/xslF345X06/doc4.xml) | Nov 16, 2026 | Nov 13, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/78003/000122520826008592/xslF345X06/doc4.xml) | Nov 3, 2026 | Oct 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/78003/000122520826008439/xslF345X06/doc4.xml) | Oct 16, 2026 | Oct 15, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/78003/000122520826008409/xslF345X06/doc4.xml) | Oct 14, 2026 | Oct 13, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/78003/000122520826008044/xslF345X06/doc4.xml) | Oct 1, 2026 | Sep 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/78003/000122520826007989/xslF345X06/doc4.xml) | Sep 29, 2026 | Sep 25, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/78003/000122520826007988/xslF345X06/doc4.xml) | Sep 29, 2026 | Sep 25, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/78003/000122520826007987/xslF345X06/doc4.xml) | Sep 29, 2026 | Sep 25, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/78003/000122520826007986/xslF345X06/doc4.xml) | Sep 29, 2026 | Sep 25, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/78003/000122520826007985/xslF345X06/doc4.xml) | Sep 29, 2026 | Sep 25, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/78003/000122520826007984/xslF345X06/doc4.xml) | Sep 29, 2026 | Sep 25, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/78003/000122520826007840/xslF345X06/doc4.xml) | Sep 16, 2026 | Sep 15, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/78003/000122520826007499/xslF345X06/doc4.xml) | Sep 1, 2026 | Aug 31, 2026 |
| [3](https://www.sec.gov/Archives/edgar/data/78003/000122520826007363/xslF345X06/doc3.xml) | Aug 28, 2026 | Aug 17, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/78003/000122520826007145/xslF345X06/doc4.xml) | Aug 17, 2026 | Aug 14, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/78003/000122520826007083/xslF345X06/doc4.xml) | Aug 12, 2026 | Aug 12, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/78003/000122520826007004/xslF345X06/doc4.xml) | Aug 6, 2026 | Aug 5, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/78003/000122520826006944/xslF345X06/doc4.xml) | Aug 5, 2026 | Aug 5, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/78003/000122520826006943/xslF345X06/doc4.xml) | Aug 5, 2026 | Aug 5, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/78003/000122520826006900/xslF345X06/doc4.xml) | Aug 3, 2026 | Jul 31, 2026 |

The latest 20 of 735 in EDGAR's recent list. Each form is filed by the insider about their own holding; the trade details are inside the form on sec.gov. Counts include amendments. The current month is counted to date.

### Ownership reports (Schedules 13D and 13G)

Pfizer: Schedule 13D and 13G beneficial ownership reports

| Form | Filed | Event date |
| --- | --- | --- |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/78003/000007800326000118/xslSCHEDULE_13G_X01/primary_doc.xml) | Oct 16, 2026 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/78003/000007800326000067/xslSCHEDULE_13G_X01/primary_doc.xml) | May 12, 2026 | — |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/78003/000210011926001294/xslSCHEDULE_13G_X02/primary_doc.xml) | May 1, 2026 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/78003/000010290926002101/xslSCHEDULE_13G_X02/primary_doc.xml) | Mar 27, 2026 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/78003/000007800326000022/xslSCHEDULE_13D_X01/primary_doc.xml) | Feb 13, 2026 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/78003/000007800326000020/xslSCHEDULE_13G_X01/primary_doc.xml) | Feb 13, 2026 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/78003/000007800326000018/xslSCHEDULE_13G_X01/primary_doc.xml) | Feb 13, 2026 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/78003/000007800325000079/xslSCHEDULE_13D_X01/primary_doc.xml) | Mar 24, 2025 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/78003/000007800325000074/xslSCHEDULE_13D_X01/primary_doc.xml) | Mar 20, 2025 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/78003/000007800325000052/xslSCHEDULE_13D_X01/primary_doc.xml) | Feb 27, 2025 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/78003/000007800325000042/xslSCHEDULE_13G_X01/primary_doc.xml) | Feb 12, 2025 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/78003/000007800325000040/xslSCHEDULE_13G_X01/primary_doc.xml) | Feb 12, 2025 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/78003/000007800325000013/xslSCHEDULE_13D_X01/primary_doc.xml) | Jan 21, 2025 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/78003/000007800325000005/xslSCHEDULE_13D_X01/primary_doc.xml) | Jan 16, 2025 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/78003/000007800324000183/a13d-a10_10324.htm) | Oct 3, 2024 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/78003/000007800324000179/sch13a_9-930.htm) | Oct 1, 2024 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/78003/000007800324000168/sch13acere8124.htm) | Aug 5, 2024 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/78003/000007800324000153/sch13da-july2024.htm) | Jul 29, 2024 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/78003/000007800324000082/hln13d-a7.htm) | Mar 22, 2024 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/78003/000007800324000080/hln13d-a31924.htm) | Mar 19, 2024 | — |

The latest 20 of 74 in EDGAR's recent list. Filed by the holder, not the company. EDGAR's list names the form and date; who filed it is in the document.

### Proxy statements

Pfizer: proxy statements and proxy materials

| Form | Filed | Meeting or period | Document |
| --- | --- | --- | --- |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/78003/000007800326000035/a2026noticeandaccess.htm) | Mar 12, 2026 | — |  |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/78003/000007800326000033/pfe-20260312.htm) | Mar 12, 2026 | Apr 23, 2026 | Definitive proxy statement |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/78003/000007800325000102/supplemental041125.htm) | Apr 11, 2025 | — |  |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/78003/000007800325000098/supplementalc041025.htm) | Apr 10, 2025 | — |  |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/78003/000007800325000095/supplementalb041025.htm) | Apr 10, 2025 | — |  |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/78003/000007800325000092/supplementala041025.htm) | Apr 10, 2025 | — |  |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/78003/000007800325000083/supplemental040725.htm) | Apr 7, 2025 | — |  |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/78003/000007800325000064/pfizer2025noticeandaccess.htm) | Mar 13, 2025 | — |  |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/78003/000007800325000062/pfe-20250313.htm) | Mar 13, 2025 | Apr 24, 2025 | Definitive proxy statement |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/78003/000007800324000097/pfe3inv.htm) | Apr 11, 2024 | — | DEFA14A EMAIL |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/78003/000007800324000096/pfe2inv.htm) | Apr 11, 2024 | — | DEFA14A MEDIA |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/78003/000007800324000095/pfe1inv.htm) | Apr 11, 2024 | — | DEFA14A MEDIA |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/78003/000007800324000094/votereminder24_defax14a.htm) | Apr 9, 2024 | — | DEFA14A VOTE REMINDER |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/78003/000007800324000088/pfizer-supplementalfiling3.htm) | Mar 28, 2024 | — | PFIZER PROXY SUPPLEMENT |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/78003/000007800324000086/pfe_-xproxyxsupplement1224.htm) | Mar 28, 2024 | — | DEFA14A PFIZER SUPPLEMENT PROXY |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/78003/000007800324000070/noticeaccess2024.htm) | Mar 14, 2024 | — | DEFA14A NOTICE |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/78003/000007800324000068/pfe-20240313.htm) | Mar 14, 2024 | Apr 25, 2024 | DEF 14A PFIZER PROXY |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/78003/000007800323000068/pfe_media.htm) | Apr 10, 2023 | — | DEFA14A MEDIA |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/78003/000007800323000067/pfe_eml.htm) | Apr 10, 2023 | — | DEFA14A EMAIL |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/78003/000007800323000061/pfevote23.htm) | Mar 30, 2023 | — |  |

The latest 20 of 32 in EDGAR's recent list.

**Everything else (75 filings: registrations, prospectuses, Rule 144 notices, correspondence and more)**

Pfizer: other SEC filings

| Form | Filed | Period | Document |
| --- | --- | --- | --- |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/78003/000007800326000135/xslForm13F_X02/primary_doc.xml) | Nov 12, 2026 | Sep 30, 2026 |  |
| [N-PX](https://www.sec.gov/Archives/edgar/data/78003/000007800326000111/xslN-PX_X01/primary_doc.xml) | Aug 31, 2026 | Jun 30, 2026 |  |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/78003/000007800326000102/xslForm13F_X02/primary_doc.xml) | Aug 13, 2026 | Jun 30, 2026 |  |
| [11-K](https://www.sec.gov/Archives/edgar/data/78003/000007800326000080/pfe-20260616.htm) | Jun 16, 2026 | Dec 31, 2025 |  |
| [11-K](https://www.sec.gov/Archives/edgar/data/78003/000007800326000078/pfe-20260615.htm) | Jun 16, 2026 | Dec 31, 2025 |  |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/78003/000007800326000064/xslForm13F_X02/primary_doc.xml) | May 12, 2026 | Mar 31, 2026 |  |
| [S-8](https://www.sec.gov/Archives/edgar/data/78003/000007800326000058/forms-82019planamended2026.htm) | May 5, 2026 | — | Registration statement for employee plans |
| [ARS](https://www.sec.gov/Archives/edgar/data/78003/000007800326000038/pfe-ars2026.pdf) | Mar 12, 2026 | Dec 31, 2025 |  |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/78003/000007800326000013/xslForm13F_X02/primary_doc.xml) | Feb 12, 2026 | Dec 31, 2025 |  |
| [424B5](https://www.sec.gov/Archives/edgar/data/78003/000119312525289779/d95338d424b5.htm) | Nov 20, 2025 | — | Prospectus |
| [FWP](https://www.sec.gov/Archives/edgar/data/78003/000119312525286519/d72904dfwp.htm) | Nov 19, 2025 | — |  |
| [424B3](https://www.sec.gov/Archives/edgar/data/78003/000119312525285360/d55952d424b3.htm) | Nov 18, 2025 | — | Prospectus |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/78003/000007800325000161/xslForm13F_X02/primary_doc.xml) | Nov 13, 2025 | Sep 30, 2025 |  |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/78003/000007800325000142/xslForm13F_X02/primary_doc.xml) | Aug 11, 2025 | Jun 30, 2025 |  |
| [11-K](https://www.sec.gov/Archives/edgar/data/78003/000007800325000132/pfizersavingsplanforemploy.htm) | Jun 16, 2025 | Dec 31, 2024 |  |
| [11-K](https://www.sec.gov/Archives/edgar/data/78003/000007800325000130/pfizersavingsplan2024.htm) | Jun 16, 2025 | Dec 31, 2024 |  |
| [SD](https://www.sec.gov/Archives/edgar/data/78003/000007800325000124/formsdye2024.htm) | May 30, 2025 | — | Specialized disclosure report |
| [144](https://www.sec.gov/Archives/edgar/data/78003/000195917325003458/xsl144X01/primary_doc.xml) | May 23, 2025 | — | Notice of proposed sale |
| [CERT](https://www.sec.gov/Archives/edgar/data/78003/000087666125000361/PFENotes052025.pdf) | May 20, 2025 | — | NYSE CERTIFICATION |
| [8-A12B](https://www.sec.gov/Archives/edgar/data/78003/000119312525122529/d61751d8a12b.htm) | May 19, 2025 | — |  |
| [424B5](https://www.sec.gov/Archives/edgar/data/78003/000119312525120844/d910320d424b5.htm) | May 15, 2025 | — | Prospectus |
| [FWP](https://www.sec.gov/Archives/edgar/data/78003/000119312525119917/d945917dfwp.htm) | May 14, 2025 | — |  |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/78003/000007800325000118/xslForm13F_X02/primary_doc.xml) | May 13, 2025 | Mar 31, 2025 |  |
| [424B3](https://www.sec.gov/Archives/edgar/data/78003/000119312525118319/d910320d424b3.htm) | May 13, 2025 | — | Prospectus |
| [POSASR](https://www.sec.gov/Archives/edgar/data/78003/000119312525118300/d915273dposasr.htm) | May 13, 2025 | — |  |
| [144](https://www.sec.gov/Archives/edgar/data/78003/000195917325002890/xsl144X01/primary_doc.xml) | May 5, 2025 | — | Notice of proposed sale |
| [PX14A6G](https://www.sec.gov/Archives/edgar/data/78003/000121465925004772/b325252px14a6g.htm) | Mar 25, 2025 | — |  |
| [ARS](https://www.sec.gov/Archives/edgar/data/78003/000007800325000066/pfe-ars2025.pdf) | Mar 13, 2025 | Dec 31, 2024 |  |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/78003/000007800325000048/xslForm13F_X02/primary_doc.xml) | Feb 14, 2025 | Dec 31, 2024 |  |
| [SC TO-I (amended)](https://www.sec.gov/Archives/edgar/data/78003/000007800324000175/pfe_toa2.htm) | Sep 13, 2024 | — | PFIZER SC TO-I/A AMENDMENT 2 FINAL |
| [CORRESP](https://www.sec.gov/Archives/edgar/data/78003/000093041324002370/filename1.htm) | Aug 22, 2024 | — |  |
| [SC TO-I (amended)](https://www.sec.gov/Archives/edgar/data/78003/000093041324002369/c109722_sctoia.htm) | Aug 22, 2024 | — |  |
| [UPLOAD](https://www.sec.gov/Archives/edgar/data/78003/000000000024009384/filename1.pdf) | Aug 15, 2024 | — |  |
| [SC TO-I](https://www.sec.gov/Archives/edgar/data/78003/000093041324002290/c109722_sctoi.htm) | Aug 12, 2024 | — |  |
| [SC TO-C](https://www.sec.gov/Archives/edgar/data/78003/000007800324000162/scto-c_pre731.htm) | Aug 1, 2024 | — | SC TO-C PRE COMMUNICATION |
| [SC TO-C](https://www.sec.gov/Archives/edgar/data/78003/000007800324000159/scto-c_pre730.htm) | Jul 30, 2024 | — | SC TO-C PRE COMMUNICATUNS |
| [SC TO-C](https://www.sec.gov/Archives/edgar/data/78003/000007800324000146/pfe8k72424.htm) | Jul 26, 2024 | — | PFIZER SC TO-C |
| [11-K](https://www.sec.gov/Archives/edgar/data/78003/000007800324000124/pfizersavingsplanforemploy.htm) | Jun 11, 2024 | Dec 31, 2023 |  |
| [11-K](https://www.sec.gov/Archives/edgar/data/78003/000007800324000122/pfizersavingsplan2023.htm) | Jun 11, 2024 | Dec 31, 2023 |  |
| [SD](https://www.sec.gov/Archives/edgar/data/78003/000007800324000116/pfizerformsdfye2023wd.htm) | May 31, 2024 | — | PFIZER FORM SD |
| [S-8](https://www.sec.gov/Archives/edgar/data/78003/000007800324000110/forms-8ar2019plan_52024.htm) | May 9, 2024 | — | PFIZER S-8 |
| [PX14A6G](https://www.sec.gov/Archives/edgar/data/78003/000121465924006888/o415249px14a6g.htm) | Apr 16, 2024 | — |  |
| [ARS](https://www.sec.gov/Archives/edgar/data/78003/000007800324000072/arsatt24.pdf) | Mar 14, 2024 | Dec 31, 2023 |  |
| [S-3ASR](https://www.sec.gov/Archives/edgar/data/78003/000119312524044552/d718279ds3asr.htm) | Feb 23, 2024 | — | FORM S-3 |
| [S-8](https://www.sec.gov/Archives/edgar/data/78003/000007800324000052/pfizers822324wd.htm) | Feb 23, 2024 | — | S-8 PFIZER INC |
| [144](https://www.sec.gov/Archives/edgar/data/78003/000195917323003921/xsl144X01/primary_doc.xml) | Sep 13, 2023 | — | Notice of proposed sale |
| [11-K](https://www.sec.gov/Archives/edgar/data/78003/000007800323000077/pfizersavingsplanforemploy.htm) | Jun 20, 2023 | Dec 31, 2022 |  |
| [11-K](https://www.sec.gov/Archives/edgar/data/78003/000007800323000075/pfizersavingsplan2022.htm) | Jun 20, 2023 | Dec 31, 2022 |  |
| [424B5](https://www.sec.gov/Archives/edgar/data/78003/000119312523148218/d502458d424b5.htm) | May 18, 2023 | — | Prospectus |
| [FWP](https://www.sec.gov/Archives/edgar/data/78003/000119312523146344/d510144dfwp.htm) | May 17, 2023 | — |  |
| [424B3](https://www.sec.gov/Archives/edgar/data/78003/000119312523144205/d502458d424b3.htm) | May 15, 2023 | — | Prospectus |
| [POSASR](https://www.sec.gov/Archives/edgar/data/78003/000119312523144191/d381947dposasr.htm) | May 15, 2023 | — |  |
| [PX14A6G](https://www.sec.gov/Archives/edgar/data/78003/000121465923005238/d412231px14a6g.htm) | Apr 12, 2023 | — |  |
| [PX14A6G](https://www.sec.gov/Archives/edgar/data/78003/000121465923004777/b44231px14a6g.htm) | Apr 4, 2023 | — |  |
| [PX14A6G](https://www.sec.gov/Archives/edgar/data/78003/000121465923004087/x322230px14a6g.htm) | Mar 22, 2023 | — | PFIZER |
| [ARS](https://www.sec.gov/Archives/edgar/data/78003/000007800323000049/pfe_arsfl.pdf) | Mar 17, 2023 | Dec 31, 2022 |  |
| [S-8](https://www.sec.gov/Archives/edgar/data/78003/000007800323000030/pfizerforms-8febx22x23_wd.htm) | Feb 27, 2023 | — | PFIZER S-8 |
| [11-K](https://www.sec.gov/Archives/edgar/data/78003/000007800322000079/pfizersavingsplanforemploy.htm) | Jun 9, 2022 | Dec 31, 2021 |  |
| [11-K](https://www.sec.gov/Archives/edgar/data/78003/000007800322000077/pfizersavingsplan2021.htm) | Jun 9, 2022 | Dec 31, 2021 |  |
| [UPLOAD](https://www.sec.gov/Archives/edgar/data/78003/000000000022004060/filename1.pdf) | Apr 14, 2022 | — |  |

The latest 60 of 75 in EDGAR's recent list.

### What the forms are

**Form 3 — Initial statement of beneficial ownership**

An insider's first statement of holdings in the company's equity securities. Insiders are officers, directors and holders of more than 10 percent of a class of its registered equity securities.

**Form 4 — Statement of changes in beneficial ownership**

An insider's transactions in the company's equity securities, disclosed within two business days of the transaction.

**Form 144 — Notice of proposed sale**

In the SEC's Forms Index: notice of proposed sale of securities pursuant to Rule 144.

**Form 10-K — Annual report**

Audited annual financial statements, a discussion of material risk factors, and management's discussion and analysis of the results for the prior fiscal year.

**Form 10-Q — Quarterly report**

Unaudited quarterly financial statements, updates on material risks, and management's discussion and analysis of the results for the prior fiscal quarter.

**Form 8-K — Current report**

Discloses material events or information the company chooses or is required to make public before its next scheduled quarterly or annual report. Each report lists the items it covers.

**Schedule 13D — Schedule 13D beneficial ownership report**

Filed when a party acquires more than five percent of a class of the company's registered voting securities; also used to disclose later changes to the holding.

**Schedule 13G — Schedule 13G beneficial ownership report**

Filed when a party acquires more than five percent of a class of the company's registered voting securities as a passive investment.

**Form DEF 14A — Definitive proxy statement**

The final proxy statement sent to shareholders for a shareholder meeting: the matters to be voted on, and typically executive and board compensation and who owns more than five percent.

**Form S-8 — Registration statement for employee plans**

In the SEC's Forms Index: registration statement under the Securities Act of 1933 for securities to be offered to employees under certain plans.

**Form S-3 — Short-form registration statement**

An abbreviated registration statement available to certain already-reporting companies to register the offer and sale of securities to the public.

**Form 424B — Prospectus**

A document disclosing information about the company and an offering; it typically makes up a large part of the registration statement.

**Form SD — Specialized disclosure report**

In the SEC's Forms Index: Specialized Disclosure Report.

From the SEC's own descriptions: [SEC, Using EDGAR to Research Investments](https://www.sec.gov/search-filings/edgar-search-assistance/using-edgar-research-investments); [SEC, Forms Index](https://www.sec.gov/submit-filings/forms-index); [SEC, Form 8-K and its items (PDF)](https://www.sec.gov/files/form8-k.pdf).

### Questions and answers

**Where is Pfizer's latest annual report (10-K)?**

Pfizer filed its latest Form 10-K with the SEC on February 26, 2026 for the period ended December 31, 2025. The table of annual and quarterly reports on this page links to the document on sec.gov.

**When did Pfizer file its latest 10-Q?**

On November 3, 2026 for the period ended September 27, 2026. A Form 10-Q holds unaudited quarterly financial statements and management's discussion of the quarter.

**What has Pfizer reported on Form 8-K recently?**

Its latest 8-K was filed on November 3, 2026 (5.02 Departure or Election of Directors or Officers; Officer Compensation). In the last twelve months the items it reported most often were: 2.02 Results of Operations and Financial Condition (4 reports); 5.02 Departure or Election of Directors or Officers; Officer Compensation (2 reports); 7.01 Regulation FD Disclosure (2 reports). An 8-K discloses material events before the next quarterly or annual report.

**How many insider filings (Forms 3, 4 and 5) were there for PFE in the last year?**

90 insider forms in the twelve months to November 18, 2026, the latest a Form 4 filed on November 16, 2026. Officers, directors and holders of more than 10 percent of a class of the company's registered equity securities must disclose their holdings and transactions; a Form 4 is due within two business days of a trade.

**Has anyone reported owning more than 5% of Pfizer?**

EDGAR lists 7 Schedule 13D or 13G filings about Pfizer in the last twelve months, the latest on October 16, 2026. These are filed by a party that acquires more than five percent of a class of the company's voting securities; 13G is for passive investors.

### Learn

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Pfizer (PFE) SEC filings: latest 10-K, 10-Q and 8-K”, data as of 18 November 2026. https://funkfolio.com/stock/PFE/filings

Underlying data: SEC EDGAR submissions (data.sec.gov).
